Roundup Lawsuit Update: Key Verdicts and Legal Insights

The Roundup lawsuit has been a significant legal saga, with thousands of individuals claiming that exposure to the popular weedkiller, Roundup, caused them to develop cancer, particularly non-Hodgkin’s lymphoma. As of 2026, the legal battles continue, with important verdicts and developments shaping the outcome for both plaintiffs and the manufacturer, Bayer (which acquired Monsanto, the creator of Roundup, in 2018). This article highlights key verdicts and legal insights into the ongoing Roundup lawsuit, offering a closer look at the latest court decisions and what they mean for future claims.

Understanding the Roundup Lawsuit

The Roundup lawsuit began after the International Agency for Research on Cancer (IARC) classified glyphosate, the active ingredient in Roundup, as "probably carcinogenic to humans" in 2015. This led to a wave of lawsuits from people who used Roundup regularly and later developed cancer. The lawsuits accuse Monsanto, and later Bayer, of failing to warn users about the cancer risks associated with glyphosate. While Bayer continues to defend the safety of its product, many juries have sided with plaintiffs, resulting in major verdicts and settlements.

Key Verdicts in the Roundup Lawsuit

1. The Landmark 2018 Verdict in California

One of the most significant early verdicts in the Roundup lawsuit came in 2018, when a California jury awarded $289 million in damages to Dewayne "Lee" Johnson, a former school groundskeeper who claimed that his prolonged exposure to Roundup led to his diagnosis of non-Hodgkin’s lymphoma. The jury found that Monsanto had failed to warn Johnson of the risks associated with its product, and they determined that the company acted with "malice or oppression." While the award was later reduced to $78 million, it set a precedent for future lawsuits, showing that juries were willing to hold Monsanto accountable.

2. Subsequent Large Awards and Settlements

Following Johnson’s case, other plaintiffs also achieved favorable verdicts. In 2019, another California jury awarded $2 billion to a couple, Alva and Alberta Pilliod, who both developed cancer after using Roundup for years. This decision was later reduced to $87 million on appeal. The large sums awarded in these cases signaled that juries viewed Monsanto’s handling of the glyphosate risk as particularly negligent.

However, Bayer, which inherited the legal challenges after acquiring Monsanto, continued to appeal many of these verdicts. The company’s defense hinges on the assertion that glyphosate is safe and that the scientific consensus supports its use, despite the findings of the IARC.

3. The 2025 Jury Verdict and Appeals

In 2025, another crucial verdict was delivered in a Missouri courtroom. The jury awarded $50 million in damages to a plaintiff who argued that his exposure to Roundup contributed to his diagnosis of non-Hodgkin’s lymphoma. Bayer has consistently appealed such verdicts, but the company faces mounting pressure as more cases move forward. The consistent pattern of juries siding with plaintiffs has made the Roundup lawsuit a key issue for Bayer’s legal team.

Legal Insights from the Roundup Lawsuit

1. The Role of Science and Expert Testimony

A critical element of the Roundup lawsuit has been the role of scientific evidence and expert testimony. Plaintiffs often rely on expert witnesses who testify about the carcinogenic potential of glyphosate. These experts point to studies linking glyphosate exposure to an increased risk of non-Hodgkin’s lymphoma. On the other hand, Bayer has presented its own experts who argue that glyphosate is safe, emphasizing studies that show no conclusive evidence linking the chemical to cancer. The ongoing battle over which side’s scientific evidence is more compelling has been central to the litigation.

2. The Impact of Settlements

As the Roundup lawsuit has progressed, Bayer has sought to resolve claims through settlements. In 2020, Bayer announced a $10 billion settlement plan, which was intended to resolve most of the claims related to Roundup. While this settlement has helped resolve a large number of cases, many plaintiffs have chosen to opt out of the settlement or continue their lawsuits individually. This has kept the litigation process ongoing, with new trials scheduled each year.

The Future of the Roundup Lawsuit

1. Ongoing Legal Challenges

As of 2026, the Roundup lawsuit remains far from over. With thousands of plaintiffs still seeking compensation and new cases continuing to be filed, the outcome of future trials will be critical. Bayer’s legal team is likely to continue appealing adverse verdicts, while plaintiffs will push for larger settlements and higher compensation for their suffering.

2. Global Implications

The Roundup lawsuit has global implications. Other countries, including France, Germany, and Canada, are grappling with whether to restrict or ban the use of glyphosate based on health concerns raised by the lawsuits. Depending on the legal outcomes in the U.S., other nations may follow suit in restricting the use of glyphosate, which could have widespread effects on agricultural practices worldwide.

Conclusion

The Roundup lawsuit continues to evolve as significant verdicts and legal insights shape the landscape of this ongoing litigation. While Bayer has made efforts to settle many claims, key verdicts in favor of plaintiffs have shown that the legal fight is far from over. As more cases go to trial and further settlements are negotiated, it is clear that the Roundup lawsuit will remain a major issue for both the agricultural industry and consumers alike. The legal insights gained from these lawsuits will not only affect the future of glyphosate but will also serve as a warning to companies regarding the importance of transparency and consumer safety in product development and marketing.